Joseph A. Sebastian

Joseph A. Sebastian

Auto-generated profile, based on publicly available information

Joseph A. Sebastian

Department of Physics, Ryerson University, Toronto, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2019 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
MMMichael J. Moore
Michael J. Moore
JSJoseph A. Sebastian
Joseph A. Sebastian
MKMichael Kolios
Michael Kolios
The development of new techniques and methods for cancer diagnosis is an active area of scientific and clinical research. Currently, the most commonly used technique for cancer diagnosis is histological assessment of tissue samples excised from the potentially cancerous tissue via optical microscopy.1 Albeit the gold standard, histological assessment of tissue samples via optical microscopy is a time-consuming and low-throughput process that lacks the ability to adequately assess three-dimensional (3-D) cell structure, a critical component of accurate diagnostics.2 One of the most prevalent characteristics of cancerous cells is an enlarged nucleus due to the increased amounts of chromatin present within malignant cells. This hallmark of malignancy led to the development of the nucleus-to-cytoplasmic (N:C) ratio, defined as the ratio of the cross-sectional area of the nucleus divided by that of cytoplasm, which has since become a commonly used parameter in tumor staging and grading.3 Most N:C assessment techniques are typically performed in two dimensional (2-D) thinly sliced histological sections; hence, they may not accurately represent the true 3-D cell structure and may not accurately represent the N:C ratio of the cells being examined. Furthermore, it has been well reported that interobserver variability exists between pathologists using optical microscopy images to calculate the N:C ratio.4 – 6

1 December 2020 in Photoacoustics
Verified
Journal Article
Open access
EHEno Hysi
Eno Hysi
MFMuhannad N. Fadhel
Muhannad N. Fadhel
YWYanjie Wang
Yanjie Wang
JSJoseph A. Sebastian
Joseph A. Sebastian
AGAnoja Giles
Anoja Giles
MKMichael Kolios
Michael Kolios
The development of novel anticancer therapies warrants the parallel development of biomarkers that can quantify their effectiveness. Photoacoustic imaging has the potential to measure changes in tumor vasculature during treatment. Establishing the accuracy of imaging biomarkers requires direct comparisons with gold histological standards. In this work, we explore whether a new class of submicron, vascular disrupting, ultrasonically stimulated nanobubbles enhance radiation therapy. In vivo experiments were conducted on mice bearing prostate cancer tumors. Combined nanobubble plus radiation treatments were compared against conventional microbubbles and radiation alone (single 8 Gy fraction). Acoustic resolution photoacoustic imaging was used to monitor the effects of the treatments 2- and 24-hs post-administration. Histological examination provided metrics of tumor vascularity and tumoral cell death, both of which were compared to photoacoustic-derived biomarkers. Photoacoustic metrics of oxygen saturation reveal a 20 % decrease in oxygenation within 24 h post-treatment. The spectral slope metric could separate the response of the nanobubble treatments from the microbubble counterparts. This study shows that histopathological assessment correlated well with photoacoustic biomarkers of treatment response.

11 July 2019 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
RPRuben N. Pinto
Ruben N. Pinto
JSJoseph A. Sebastian
Joseph A. Sebastian
MPMichael J. Parsons
Michael J. Parsons
TCTim C. Chang
Tim C. Chang
TTTracey R. Turner
Tracey R. Turner
MKMichael Kolios
Michael Kolios
Deleterious changes, collectively termed as storage lesions, alter the characteristics of red blood cell (RBC) morphology during in vitro storage. Due to gradual loss of cellular membrane, RBCs lose their original biconcave disk shape and begin a process of spherical deformation that is characterized by well‐defined morphological criteria. At the spheroechinocyte stage, the structure of RBC is irreversibly damaged and lacks the elasticity necessary to efficiently deliver oxygen. Quantifying the prevalence of spheroechinocytes could provide an important morphological measure of the quality of stored blood products. Unlike the conventional RBC morphology characterization assay involving light microscopy, we introduce a label‐free assay using imaging flow cytometry (IFC). The technique captures 100,000 images of a sample and calculates a relative measure of spheroechinocyte population in a fraction of the time required by the conventional method. A comparative method study, measuring a morphological index for 11 RCC units through storage, found that the two techniques measured similar trends with IFC reporting the metric at an average of 3.9% higher. We monitored 18 RCC units between Weeks 1 and 6 of storage and found that the spheroechinocyte population increased by an average of 26.2%. The large (3.5–64.1%) variation between the units' spheroechinocyte population percentage at Week 1 suggests a possible dependence of blood product quality on donor characteristics. Given our method's ability to rapidly monitor large samples and refine morphological characterization beyond conventional methods, we believe our technique offers good potential for studying the underlying relationships between RBC morphology and blood storage lesions. © 2019 International Society for Advancement of Cytometry

24 June 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJoseph A. Sebastian
Joseph A. Sebastian
MMMichael J. Moore
Michael J. Moore
EBElizabeth S. L. Berndl
Elizabeth S. L. Berndl
MKMichael Kolios
Michael Kolios
The nucleus-to-cytoplasm ratio (N:C) can be used as one metric in histology for grading certain types of tumor malignancy. Current N:C assessment techniques are time-consuming and low throughput. Thus, in high-throughput clinical contexts, there is a need for a technique that can assess cell malignancy rapidly. In this study, we assess the N:C ratio of four different malignant cell lines (OCI-AML-5—blood cancer, CAKI-2—kidney cancer, HT-29—colon cancer, SK-BR-3—breast cancer) and a non-malignant cell line (MCF-10A –breast epithelium) using an imaging flow cytometer (IFC). Cells were stained with the DRAQ-5 nuclear dye to stain the cell nucleus. An Amnis ImageStreamX® IFC acquired brightfield/fluorescence images of cells and their nuclei, respectively. Masking and gating techniques were used to obtain the cell and nucleus diameters for 5284 OCI-AML-5 cells, 1096 CAKI-2 cells, 6302 HT-29 cells, 3159 SK-BR-3 cells, and 1109 MCF-10A cells. The N:C ratio was calculated as the ratio of the nucleus diameter to the total cell diameter. The average cell and nucleus diameters from IFC were 12.3 ± 1.2 μm and 9.0 ± 1.1 μm for OCI-AML5 cells, 24.5 ± 2.6 μm and 15.6 ± 2.1 μm for CAKI-2 cells, 16.2 ± 1.8 μm and 11.2 ± 1.3 μm for HT-29 cells, 18.0 ± 3.7 μm and 12.5 ± 2.1 μm for SK-BR-3 cells, and 19.4 ± 2.2 μm and 10.1 ± 1.8 μm for MCF-10A cells. Here we show a general N:C ratio of ~0.6–0.7 across varying malignant cell lines and a N:C ratio of ~0.5 for a non-malignant cell line. This study demonstrates the use of IFC to assess the N:C ratio of cancerous and non-cancerous cells, and the promise of its use in clinically relevant high-throughput detection scenarios to supplement current workflows used for cancer cell grading.

18 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ESEric M. Strohm
Eric M. Strohm
VGVaskar Gnyawali
Vaskar Gnyawali
JSJoseph A. Sebastian
Joseph A. Sebastian
RNRobert Ngunjiri
Robert Ngunjiri
MMMichael J. Moore
Michael J. Moore
MKMichael Kolios
Michael Kolios
We describe a new technique that combines ultrasound and microfluidics to rapidly size and count cells in a high-throughput and label-free fashion. Using 3D hydrodynamic flow focusing, cells are streamed single file through an ultrasound beam where ultrasound scattering events from each individual cell are acquired. The ultrasound operates at a center frequency of 375 MHz with a wavelength of 4 μm; when the ultrasound wavelength is similar to the size of a scatterer, the power spectra of the backscattered ultrasound waves have distinct features at specific frequencies that are directly related to the cell size. Our approach determines cell sizes through a comparison of these distinct spectral features with established theoretical models. We perform an analysis of two types of cells: acute myeloid leukemia cells, where 2,390 measurements resulted in a mean size of 10.0 ± 1.7 μm, and HT29 colorectal cancer cells, where 1,955 measurements resulted in a mean size of 15.0 ± 2.3 μm. These results and histogram distributions agree very well with those measured from a Coulter Counter Multisizer 4. Our technique is the first to combine ultrasound and microfluidics to determine the cell size with the potential for multi-parameter cellular characterization using fluorescence, light scattering and quantitative photoacoustic techniques.

15 February 2023 in Biomaterials
Verified
Journal Article
Closed access
JSJoseph A. Sebastian
Joseph A. Sebastian
ESEric M. Strohm
Eric M. Strohm
JBJérôme Baranger
Jérôme Baranger
OVOlivier Villemain
Olivier Villemain
MKMichael C. Kolios
Michael C. Kolios
CSCraig A. Simmons
Craig A. Simmons